UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study

BMJ, 1998-07, Vol.317 (7151), p.119-120

International edition, 1998

Volltextzugriff (PDF)

Safety of Long‐Term Lamotrigine in Epilepsy

Epilepsia (Copenhagen), 1997-08, Vol.38 (8), p.881-886

1997

Volltextzugriff (PDF)

Safety profile of orlistat: results of a prescription-event monitoring study

International Journal of Obesity, 2006-11, Vol.30 (11), p.1645-1652

2006

Volltextzugriff (PDF)

Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England

BMJ (Online), 2001-03, Vol.322 (7287), p.651-652

International edition, 2001

Volltextzugriff (PDF)

Evaluation of the safety of sildenafil for male erectile dysfunction: experience gained in general practice use in England in 1999

BJU international, 2004-04, Vol.93 (6), p.796-801

2004

Volltextzugriff (PDF)

The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England

BJOG : an international journal of obstetrics and gynaecology, 1998-08, Vol.105 (8), p.882-889

1998

Volltextzugriff (PDF)

The safety of valsartan: results of a postmarketing surveillance study on 12 881 patients in England

Journal of human hypertension, 2002-11, Vol.16 (11), p.795-803

2002

Volltextzugriff (PDF)

A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies

British journal of clinical pharmacology, 1996-04, Vol.41 (4), p.277-284

1996

Volltextzugriff (PDF)

Visual field defect associated with vigabatrin: observational cohort study

BMJ, 1999-10, Vol.319 (7218), p.1165-1166

International edition, 1999

Volltextzugriff (PDF)

The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England

Journal of psychopharmacology (Oxford), 2001-12, Vol.15 (4), p.265-271

2001

Volltextzugriff (PDF)

Ron Mann's scientific contributions as the second Director of the DSRU

Pharmacoepidemiology and drug safety, 2010-08, Vol.19 (8), p.776-777

2010

Volltextzugriff (PDF)

A post-marketing observational study to assess the safety of mibefradil in the community in England

International journal of clinical pharmacology and therapeutics, 2002-06, Vol.40 (6), p.241-248

2002

Volltextzugriff (PDF)

Prescription-event monitoring and reporting of adverse drug reactions

The Lancet (British edition), 2001-12, Vol.358 (9296), p.1872-1873

2001

Volltextzugriff (PDF)

Montelukast and improvement of eczema: observations from a prescription event monitoring study in England

International journal of clinical pharmacology and therapeutics, 2001-12, Vol.39 (12), p.529-533

2001

Volltextzugriff (PDF)

Comments to regional problems of analgesic risk perception

Bratislavské lékarské listy, 2011, Vol.112 (3), p.140-142

2011

Volltextzugriff (PDF)

Losartan: a study of pharmacovigilance data on 14,522 patients

Journal of human hypertension, 1999-08, Vol.13 (8), p.551-557

1999

Volltextzugriff (PDF)

Observational cohort study to monitor the use and safety of carvedilol in the treatment of heart failure in clinical practice in England--1st interim report

International journal of clinical pharmacology and therapeutics, 2005-01, Vol.43 (1), p.1-6

2005

Volltextzugriff (PDF)

A comparison of two cohort studies evaluating the safety of cisapride : Prescription-Event Monitoring and a large phase IV study

European journal of clinical pharmacology, 1997, Vol.52 (2), p.87-94

1997

Volltextzugriff (PDF)

Troglitazone and liver function abnormalities: Lessons from a prescription Event monitoring study and spontaneous reporting

Drug safety, 2001, Vol.24 (2), p.149-154

2001

Volltextzugriff (PDF)

Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: Experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database

Drug safety, 2001, Vol.24 (15), p.1143-1154

2001

Volltextzugriff (PDF)

A Postmarketing Surveillance Study of Gabapentin as Add‐on Therapy for 3,100 Patients in England

Epilepsia (Copenhagen), 2002-09, Vol.43 (9), p.983-992

2002

Volltextzugriff (PDF)

Prospective observational cohort safety study to monitor the introduction of a non-CFC formulation of salbutamol with HFA134a in England

International journal of clinical pharmacology and therapeutics, 2003-02, Vol.41 (2), p.67-76

2003

Volltextzugriff (PDF)

Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine

Journal of psychopharmacology (Oxford), 2001-03, Vol.15 (2), p.120-126

2001

Volltextzugriff (PDF)

Pharmacovigilance study of alendronate in England

Osteoporosis international, 2003-07, Vol.14 (6), p.507-514

2003

Volltextzugriff (PDF)

Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies

Pharmacoepidemiology and drug safety, 1999-05, Vol.8 (3), p.179-189

1999

Volltextzugriff (PDF)

1 – 25 von 258

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(240)
Mit Volltextzugriff
(223)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(258)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study

Safety of Long‐Term Lamotrigine in Epilepsy

Safety profile of orlistat: results of a prescription-event monitoring study

Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England

Evaluation of the safety of sildenafil for male erectile dysfunction: experience gained in general practice use in England in 1999

The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England

The safety of valsartan: results of a postmarketing surveillance study on 12 881 patients in England

A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies

Visual field defect associated with vigabatrin: observational cohort study

The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England

Ron Mann's scientific contributions as the second Director of the DSRU

A post-marketing observational study to assess the safety of mibefradil in the community in England

Prescription-event monitoring and reporting of adverse drug reactions

Montelukast and improvement of eczema: observations from a prescription event monitoring study in England

Comments to regional problems of analgesic risk perception

Losartan: a study of pharmacovigilance data on 14,522 patients

Observational cohort study to monitor the use and safety of carvedilol in the treatment of heart failure in clinical practice in England--1st interim report

A comparison of two cohort studies evaluating the safety of cisapride : Prescription-Event Monitoring and a large phase IV study

Troglitazone and liver function abnormalities: Lessons from a prescription Event monitoring study and spontaneous reporting

Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: Experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database

A Postmarketing Surveillance Study of Gabapentin as Add‐on Therapy for 3,100 Patients in England

Prospective observational cohort safety study to monitor the introduction of a non-CFC formulation of salbutamol with HFA134a in England

Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine

Pharmacovigilance study of alendronate in England

Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies

Suchergebnisse filtern